Bilirubin as a Biomarker in Liver Disease-Reference-Cited by-同舟云学术

Bilirubin as a Biomarker in Liver Disease

Published:2016 Issue: Volume: Page:1-25
ISSN:2451-9766
Container-title:Biomarkers in Disease: Methods, Discoveries and Applications
language:
Short-container-title:

Author:

Méndez-Sánchez Nahum,Vítek Libor,Aguilar-Olivos Nancy E.,Uribe Misael

Publisher

Springer Netherlands

Link

http://link.springer.com/content/pdf/10.1007/978-94-007-7742-2_25-1

Reference101 articles.

1. Adachi Y, Inufusa H, Yamashita M, et al. Clinical application of serum bilirubin fractionation by simplified liquid chromatography. Clin Chem. 1988;34:385–8.

2. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.

3. Arroyo V, Moreau R, Jalan R, et al. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. J Hepatol. 2015;62:S131–43.

4. Balta S, Balta I, Mikhailidis DP, et al. Bilirubin levels and their association with carotid intima media thickness and high-sensitivity C-reactive protein in patients with psoriasis vulgaris. Am J Clin Dermatol. 2014;15:137–42.

5. Baranano DE, Rao M, Ferris CD, et al. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A. 2002;99:16093–8.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ti₃C₂T_xMXene modified indium tin oxide (ITO) electrode for electrochemical sensing of bilirubin based on a molecularly imprinted pyrrole polymer;Physica Scripta;2024-04-09

2. Molecularly imprinted orthophenylenediamine with Ti₃C₂T_xMXene‐based biosensor for sensitive detection of bilirubin;Polymers for Advanced Technologies;2024-03

3. Hepatoprotective effect of ethanolic extract of sugarcane (Saccharum officinarum Linn.) leaves;Journal of Basic and Clinical Physiology and Pharmacology;2021-06-25

4. When special populations intersect with drug–drug interactions: Application of physiologically‐based pharmacokinetic modeling in pregnant populations;Biopharmaceutics & Drug Disposition;2021-04